These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

928 related items for PubMed ID: 9705395

  • 1. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES, Sanders CC, Thomson KS.
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [Abstract] [Full Text] [Related]

  • 2. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
    Tofteland S, Dahl KH, Aasnæs B, Sundsfjord A, Naseer U.
    Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
    [Abstract] [Full Text] [Related]

  • 3. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology.
    Queenan AM, Foleno B, Gownley C, Wira E, Bush K.
    J Clin Microbiol; 2004 Jan; 42(1):269-75. PubMed ID: 14715764
    [Abstract] [Full Text] [Related]

  • 4. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH.
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [Abstract] [Full Text] [Related]

  • 6. In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial.
    Stewart AG, Cottrell K, Henderson A, Vemuri K, Bauer MJ, Paterson DL, Harris PNA.
    Microbiol Spectr; 2021 Sep 03; 9(1):e0022621. PubMed ID: 34232101
    [Abstract] [Full Text] [Related]

  • 7. Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut.
    Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF.
    J Clin Microbiol; 1999 Dec 03; 37(12):4065-70. PubMed ID: 10565933
    [Abstract] [Full Text] [Related]

  • 8. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group.
    J Clin Microbiol; 2007 Jan 03; 45(1):199-205. PubMed ID: 17079502
    [Abstract] [Full Text] [Related]

  • 9. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
    Vercauteren E, Descheemaeker P, Ieven M, Sanders CC, Goossens H.
    J Clin Microbiol; 1997 Sep 03; 35(9):2191-7. PubMed ID: 9276386
    [Abstract] [Full Text] [Related]

  • 10. [Analysis of antibiotic resistance and genotypes on extended spectrum β-lactamase and AmpC β-lactamase producing strains isolated from Uygur and Han newborns].
    Zhang WL, Liu J, Zhang J, Su GL.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar 03; 45(3):217-24. PubMed ID: 21624232
    [Abstract] [Full Text] [Related]

  • 11. Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates.
    Blahová J, Hupková M, Králiková K, Krcméry V, Lísková A, Kubonová K.
    Zentralbl Bakteriol; 1998 Jul 03; 288(1):75-86. PubMed ID: 9728407
    [Abstract] [Full Text] [Related]

  • 12. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P, Metan G, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2007 Oct 03; 41(4):579-84. PubMed ID: 18173077
    [Abstract] [Full Text] [Related]

  • 13. Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.
    Thomson KS, Sanders CC, Moland ES.
    Antimicrob Agents Chemother; 1999 Jun 03; 43(6):1393-400. PubMed ID: 10348759
    [Abstract] [Full Text] [Related]

  • 14. Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates.
    Hadziyannis E, Tuohy M, Thomas L, Procop GW, Washington JA, Hall GS.
    Diagn Microbiol Infect Dis; 2000 Feb 03; 36(2):113-7. PubMed ID: 10705053
    [Abstract] [Full Text] [Related]

  • 15. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C, Yetkin F, Görgeç S, Ersoy Y.
    Mikrobiyol Bul; 2011 Jan 03; 45(1):28-35. PubMed ID: 21341156
    [Abstract] [Full Text] [Related]

  • 16. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 Jan 03; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 17. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
    Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, Williams PP, Brittain KL, Oliver A, McGowan JE, Tenover FC.
    J Clin Microbiol; 2001 Aug 03; 39(8):2864-72. PubMed ID: 11474005
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of the MicroScan NegCombo panel Type 44 for detection of extended-spectrum beta-lactamase among clinical isolates of Escherichia coli, Klebsiella species, and Proteus mirabilis].
    Ko SY, Chung JW, Song AJ, Yoon NS, Sung H, Kim MN.
    Korean J Lab Med; 2009 Feb 03; 29(1):35-40. PubMed ID: 19262076
    [Abstract] [Full Text] [Related]

  • 19. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.
    Int J Infect Dis; 2008 May 03; 12(3):256-64. PubMed ID: 17981482
    [Abstract] [Full Text] [Related]

  • 20. Dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli in Thai hospitals.
    Niumsup PR, Tansawai U, Boonkerd N, Polwichai P, Dejsirilert S.
    J Infect Chemother; 2008 Dec 03; 14(6):404-8. PubMed ID: 19089552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.